Saturday, October 3, 2026

BTC $84,627 ▼ 2.12%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$84,627−2.12%ETH$2,683−2.40%SOL$119.32−2.41%XRP$1.48−3.77%LINK$13.92−3.59%ADA$0.245−4.26%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,162.30−0.95%SILVER$60.42−1.24%OIL$91.11−1.90%DXY101.92−0.01%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed67 — GreedBTC$84,627−2.12%ETH$2,683−2.40%SOL$119.32−2.41%XRP$1.48−3.77%LINK$13.92−3.59%ADA$0.245−4.26%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,162.30−0.95%SILVER$60.42−1.24%OIL$91.11−1.90%DXY101.92−0.01%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed67 — Greed

Tag

regeneron

1 article

U.S. Equities137d ago

Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal

Regeneron's geographic atrophy treatment met primary endpoint in Phase 3 trial while Mobileye landed multi-year European automaker contract